Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 10, 2021 12:18pm
128 Views
Post# 32526088

RE:RE:RE:RE:Just added to my position....SZLS

RE:RE:RE:RE:Just added to my position....SZLSAgreed.  Tripp should be making an announcement of a partnership, or maybe some interm reveenue numbers or just an operational update.  Than a HALT with the announcement of Aristotle and than more announcements of partnerships.  Is he really going to wait until the end of March??

capebretongirl wrote: Unfortunately Rebecca doesn't have much say as regards NRs - Tripp calls the shots and as a scientist he is focussed on just that. The timing of NRs does not seem to be a consideration for him despite his stated desire to one day have a NASDAQ listing. It would be ideal to have a senior business oriented PR position on the board with the autonomy to release NRs as required - separate from any input from Tripp - such business input would keep investors informed/engaged during the most exciting period for this stock read: now. Despite the many positives currently being experienced, investors are left to identify them via social media and google - the result being that we are not experiencing the sp potential that other stocks are currently benefitting from.


<< Previous
Bullboard Posts
Next >>